JP2012115277A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012115277A5 JP2012115277A5 JP2012020504A JP2012020504A JP2012115277A5 JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5 JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- polypeptide according
- yrkyrkryyyrkyrkryy
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 208000036142 Viral infection Diseases 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101150037123 APOE gene Proteins 0.000 claims 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0329254.7 | 2003-12-17 | ||
| GBGB0329254.7A GB0329254D0 (en) | 2003-12-17 | 2003-12-17 | Treatment of viral infections |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Division JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012115277A JP2012115277A (ja) | 2012-06-21 |
| JP2012115277A5 true JP2012115277A5 (Direct) | 2013-06-27 |
Family
ID=30471239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Pending JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
| JP2012020504A Pending JP2012115277A (ja) | 2003-12-17 | 2012-02-02 | ウイルス感染の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Pending JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7691382B2 (Direct) |
| EP (2) | EP2277911A1 (Direct) |
| JP (2) | JP2007535910A (Direct) |
| CN (2) | CN1894281B (Direct) |
| AU (1) | AU2004299343B8 (Direct) |
| CA (1) | CA2548585A1 (Direct) |
| DK (1) | DK1709075T3 (Direct) |
| ES (1) | ES2389078T3 (Direct) |
| GB (1) | GB0329254D0 (Direct) |
| PL (1) | PL1709075T3 (Direct) |
| WO (1) | WO2005058959A2 (Direct) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
| GB0329958D0 (en) | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
| GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
| GB0513096D0 (en) * | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
| WO2007030930A1 (en) | 2005-09-13 | 2007-03-22 | National Research Council Of Canada | Methods and compositions for modulating tumor cell activity |
| PL2085774T3 (pl) * | 2008-02-01 | 2018-08-31 | Kraft Foods R & D, Inc. | Sposób określania konsystencji materiału spożywczego |
| WO2009102715A2 (en) * | 2008-02-11 | 2009-08-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Peptide therapy for ocular herpes infections |
| WO2009101807A1 (ja) * | 2008-02-14 | 2009-08-20 | National University Corporation Kyoto Institute Of Technology | ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法 |
| US8802826B2 (en) | 2009-11-24 | 2014-08-12 | Alethia Biotherapeutics Inc. | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| US20120053128A1 (en) * | 2010-08-26 | 2012-03-01 | Xavier University | Method of inhibiting angiogenesis |
| US9234026B2 (en) | 2011-07-21 | 2016-01-12 | University of Pittsburgh—of the Commonwealth System of Higher Education | Apolipoprotein E polypeptides and their use |
| EP2817028A4 (en) | 2012-02-22 | 2015-11-04 | Alethia Biotherapeutics Inc | COMMON USE OF A CLUSTERIN INHIBITOR AND EGFR INHIBITOR FOR TREATING CANCER |
| WO2013148305A1 (en) * | 2012-03-29 | 2013-10-03 | Xavier University Of Louisiana | Method for treating diabetic retinopathy |
| WO2016054310A1 (en) | 2014-10-01 | 2016-04-07 | Plant Health Care, Inc. | Hypersensitive response elicitor peptides and use thereof |
| WO2016054250A1 (en) * | 2014-10-01 | 2016-04-07 | Cascadia Life Sciences Llc | Anti-viral peptides |
| RU2017114801A (ru) | 2014-10-01 | 2018-11-06 | Плант Хелс Кэар, Инк. | Элиситорные пептиды, имеющие разрушенный бокс гиперчувствительного ответа, и их применение |
| WO2017176588A1 (en) | 2016-04-06 | 2017-10-12 | Plant Health Care, Inc. | Beneficial microbes for delivery of effector peptides or proteins and use thereof |
| EP3439682B1 (en) | 2016-04-06 | 2025-08-13 | Plant Health Care, Inc. | Hypersensitive response elicitor-derived peptides and use thereof |
| EP3962925A4 (en) * | 2019-04-30 | 2023-08-23 | Maxwell Biosciences, Inc. | HALOGENATED ANTIMICROBIAL PEPTOIDS |
| CN116813712B (zh) * | 2023-06-16 | 2024-03-29 | 东北农业大学 | 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5473039A (en) * | 1989-08-18 | 1995-12-05 | The Scripps Research Institute | Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs |
| WO1993000443A1 (en) * | 1991-06-26 | 1993-01-07 | Bio-Technology General Corp. | Purification of recombinant apolipoprotein e from bacteria |
| US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
| JP2001518449A (ja) * | 1997-09-30 | 2001-10-16 | デューク・ユニバーシティー | アポリポタンパク質ｅ／成長因子複合体およびその使用法 |
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| GB0200757D0 (en) * | 2002-01-15 | 2002-02-27 | Univ Manchester | Diagnostic methods |
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
-
2003
- 2003-12-17 GB GBGB0329254.7A patent/GB0329254D0/en not_active Ceased
-
2004
- 2004-12-17 ES ES04806160T patent/ES2389078T3/es not_active Expired - Lifetime
- 2004-12-17 CN CN2004800379084A patent/CN1894281B/zh not_active Expired - Fee Related
- 2004-12-17 WO PCT/GB2004/005360 patent/WO2005058959A2/en not_active Ceased
- 2004-12-17 JP JP2006544559A patent/JP2007535910A/ja active Pending
- 2004-12-17 CA CA002548585A patent/CA2548585A1/en not_active Abandoned
- 2004-12-17 AU AU2004299343A patent/AU2004299343B8/en not_active Ceased
- 2004-12-17 EP EP10010764A patent/EP2277911A1/en not_active Withdrawn
- 2004-12-17 PL PL04806160T patent/PL1709075T3/pl unknown
- 2004-12-17 DK DK04806160.0T patent/DK1709075T3/da active
- 2004-12-17 CN CN2011102495236A patent/CN102336815A/zh active Pending
- 2004-12-17 US US10/580,761 patent/US7691382B2/en not_active Expired - Lifetime
- 2004-12-17 EP EP04806160A patent/EP1709075B9/en not_active Expired - Lifetime
-
2010
- 2010-02-09 US US12/702,919 patent/US20100221273A1/en not_active Abandoned
-
2012
- 2012-02-02 JP JP2012020504A patent/JP2012115277A/ja active Pending
- 2012-07-16 US US13/550,029 patent/US20130150288A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012115277A5 (Direct) | ||
| JP2012126742A5 (Direct) | ||
| JP2010166916A5 (Direct) | ||
| JP2012136541A5 (Direct) | ||
| JP2012082206A5 (Direct) | ||
| JP2015517489A5 (Direct) | ||
| JP2011528896A5 (Direct) | ||
| JP2016509011A5 (Direct) | ||
| JP2012176978A5 (Direct) | ||
| JP2011528901A5 (Direct) | ||
| JP2010227101A5 (Direct) | ||
| RU2015119517A (ru) | Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1 | |
| JP2012529293A5 (Direct) | ||
| JP2011528895A5 (Direct) | ||
| JP2015514132A5 (Direct) | ||
| JP2010508030A5 (Direct) | ||
| JP2015533791A5 (Direct) | ||
| JP2007535910A5 (Direct) | ||
| JP2015520178A5 (Direct) | ||
| JP2011528897A5 (Direct) | ||
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| JP2019513752A5 (Direct) | ||
| JP2018512124A5 (Direct) | ||
| JP2015521206A5 (Direct) | ||
| JP2014529399A5 (Direct) |